Skip to content
Get alerts
GovInfoNow
Use caution Medical device recall · FDA · Published May 6, 2019

Becton Dickinson Alaris Pump Infusion Set Recall: Risk of Medication Errors

Becton Dickinson recalls Alaris Pump Infusion Sets with specific model codes due to potential medication delivery errors. Affected units may cause unintended medication delivery or faster-than-expected drug flow.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #Z-1770-2019Medical deviceBecton Dickinson ›
Take action

Contact the company

Recalling firmBecton Dickinson & Company1 Becton Dr · Franklin Lakes, NJ 07417-1815
✎ GovInfoNow plain-language explainer

Becton Dickinson is recalling certain Alaris Pump Infusion Sets that could cause unintended medication delivery or faster-than-expected drug flow when the pump is not running or infusing. This risk affects patients receiving intravenous treatments. Read more at govinfonow.com/recall/67951-becton-dickinson-alaris-pump-infusion-set-recall-risk-of-medication.

Source Summary by GovInfoNow · govinfonow.com/recall/67951-becton-dickinson-alaris-pump-infusion-set-recall-risk-of-medication · Updated August 20, 2026 · FDA enforcement record: FDA #Z-1770-2019

Cite this page

“Becton Dickinson Alaris Pump Infusion Set Recall: Risk of Medication Errors.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/67951-becton-dickinson-alaris-pump-infusion-set-recall-risk-of-medication. Based on FDA recall #Z-1770-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1770-2019%22&limit=1).

Becton Dickinson & Company recalled Alaris Pump Infusion Sets on May 6, 2019, according to the FDA. The hazard involves potential unintended medication delivery due to wall thickness variations in the pumping segment.

How to tell if you have it

  • Brand: Becton Dickinson
  • Product: Alaris Pump Infusion Set
  • Model Codes: 10010453, 10010454, 10012144, 10015294, 10015414, 10933805, 11171447, 11404930, 11522558, 11607704, 10013361T, 2110-0500, 2126-0500, 2200-0500, 2411-0500, 2419-0007, 2420-0007, 2420-0500, 2421-0500, 2426-0007, 2426-0500, 2429-0500, 2433-0007, 2477-0000, 2477-0007, 2478-0000, C24116E
  • Expiration Dates: 05/2019 through 08/2020
  • Distribution: Worldwide, including US states AK-WY and PR, and countries Australia, Belgium, Canada, Chile, Malaysia, Mexico, Panama, Singapore, Taiwan

The hazard

The FDA said an incomplete occlusion can be caused by a variation in the wall thickness of the pumping segment. This issue has the potential to lead to unintended delivery of medication when the pump module is not in running status or can result in faster than expected drug delivery flow when the pump is infusing.

Context

GovInfoNow's records show Becton Dickinson & Company has 52 other recalls on record since 2017-05-31. Other recent recalls of similar products include BD Alaris Pump Infusion Sets Recall: Performance Data Discrepancies May Cause Inappropriate Pump Function (2026-08-19) and B Braun IV Sets Recall: Risk of Medication Backflow and Occlusion (2025-10-29).

How to tell if you have this one

Check for model codes listed in the recall: 10010453, 10010454, 10012144, 10015294, 10015414, 10933805, 11171447, 11404930, and others. The product was manufactured between May 2016 and August 2017 with expiration dates between May 2019 and August 2020.

  • Brand
    Becton Dickinson
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Model Codes

    Identify if your Alaris Pump Infusion Set has any of the listed model codes (e.g., 10010453, 10010454, etc.)

  2. Contact Manufacturer

    Reach out to Becton Dickinson for further assistance if you are unsure about your model code or need help with the recall.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 49 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide Distribution; US (nationwide distribution) to following US states: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, IL, ID, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MP, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: May 6, 201912. FDA classified it Class I: Jul 11, 201923. Published in FDA’s Enforcement Report: Jul 17, 201934. FDA terminated the recall: Jul 19, 2021420192021
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

What should I do if I have the affected model?

Contact Becton Dickinson directly to confirm if your product is affected and to get instructions on next steps.

Similar recalls

Safeguard US Recalls Battle Bandages and IFAK Kits Due to Infection Risk
Safeguard US Operating LLCMiniMed Flex Insulin Pump Recall: Inaccurate Delivery Risk
Medtronic MiniMed, Inc.Medline Bariatric Rollator Recall: Detaching Wheels Risk
Medline Industries, LPCooperVision Pearle Vision 1 Day Contact Lenses: Incorrect Power Risk
CooperVision, Inc.Tandem t:slim App Recall: Pairing Issue With Abbott Sensors
Tandem Diabetes Care, Inc.

Latest medical device recalls

BMC Medical Co., Ltd. recalls BMC/REACTHEALTH Luna G3 APAP REF LG 3600
BMC Medical Co., Ltd. · July 15, 2026Medtronic MiniMed, Inc. recalls MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
Medtr: MiniMed · July 13, 2026INTEGRATED MEDCRAFT LLC recalls Kingfisher Compact Individual First Aid Kit. REF Number: 76656. Containing the affected One-piece Guedel airway
Medcraft · July 7, 2026Pride Mobility Products Corp. recalls Brand Name: Quantum Rehab Product Name: R-TRAK Model/Catalog Number: R-TRAK Software Version: 2.0.11, new version:
Quantum Rehab · June 25, 2026ResMed Ltd. recalls Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory
ResMed · June 25, 2026Therabody, Inc recalls Charger for the Therabody Theragun, G4 PRO massage device, and products which include the 4th Generation Theragun PRO
Therabody · June 23, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1770-2019 (May 6, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1770-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA